Cambiar Investors LLC Harmony Biosciences Holdings, Inc. Transaction History

Cambiar Investors LLC

  • $2.47 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 27, 2022
SELL
$34.09 - $43.91 $2.8 Million - $3.61 Million
-82,222 Closed
0 $0
Q3 2021

Oct 22, 2021
SELL
$25.68 - $38.61 $561,390 - $844,053
-21,861 Reduced 21.0%
82,222 $3.15 Million
Q2 2021

Aug 02, 2021
BUY
$25.96 - $33.44 $753,748 - $970,930
29,035 Added 38.69%
104,083 $2.94 Million
Q1 2021

May 14, 2021
BUY
$27.56 - $40.37 $2.07 Million - $3.03 Million
75,048 New
75,048 $2.48 Million

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.2M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Cambiar Investors LLC Portfolio

Follow Cambiar Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cambiar Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email